Uri Elkayam, MD is Professor of Medicine and Professor of Obstetrics and Gynecology at the University of Southern California in Los Angeles.
Dr. Elkayam research interests include congestive heart failure, vascular biology, renal vasoregulation, cardiovascular pharmacology, nitrate tolerance, valvular heart disease in heart failure and heart disease in pregnancy. He has been involved in more then 100 self initiated, NIH and industry funded research projects and has served on the steering committees of multiple mulitcenter studies, including PRAISE I, PRAISE II, MACH-1, ACTIVE-CHF, ALIVE, ESCAPE and PURE II, and BALANCE. and served as member of the endpoint committee of the STAMINA-HeFT study and a member of the DSMB of the ongoing study BLOCK-HF.
Dr. Elkayam is a past member of the editorial board of the Journal of the American College of Cardiology and is presently a member of many national and international committees and advisory boards and serves on the editorial boards of the American Journal of Cardiology, Journal of Cardiac Failure, Heart Failure, Heart Failure Reviews, Cardiology, Journal of Preventive Cardiology and Current Cardiology Review.
Dr. Elkayam has been the recipient of a number of awards, including the Melvin L. Marcus Memorial Award for Distinguish Contribution as a gifted teacher 8th World Congress of Heart Failure in 2002 and the Richard H. Paul MD, Maternal-Fetal Medicine Distinguish Teaching Award at the University of Southern California in 2002 and the Distinguished Fellowship Award from the International Academy of Cardiology in 2007. Dr. Elkayam has the distinction of being listed in Best Doctors in America (2000-2010) and Americas Top Doctors (2001-2010).
